EUVIMEDEUVIMED entdecken
Systematische Übersicht

Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic review

Pouya Vakilipour, Saeed Sadigh-Eteghad, Amirreza Naseri, Melika Ahmadi Bonabi

Brain Research · 2026

DOI: 10.1016/j.brainres.2026.150479 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Brain Research, 2026. Verfasst von Pouya Vakilipour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Medicine, Tabriz University of Medical Sciences…. Hauptthemen laut MEDLINE: Nimodipine, Multiple Sclerosis, Demyelinating Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences Student Research Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Multiple sclerosis (MS) is the most common inflammatory neurodegenerative disease in which axonal injury, neuronal death, and demyelination occur. Treatment for MS relapses remains limited, which alleviates acute loss of function but has no impact on long-term disability. This study aimed to perform a systematic review of the effects of nimodipine on experimental demyelination models, including experimental autoimmune encephalomyelitis (EAE) and Cuprizone models in rodents. METHODS: This study was conducted following the PRISMA statement. A systematic search was performed in PubMed, Scopus, the Cochrane Library, and Google Scholar. The primary outcome was EAE clinical disease severity (peak clinical score and/or cumulative disease burden). Secondary outcomes included relapse activity (when reported), histological myelin outcomes, oligodendrocyte lineage markers, neuroaxonal injury markers, and inflammatory readouts. Risk of bias was assessed using the SYRCLE tool. RESULTS: Out of 4660 results, 5 studies were included in the systematic review (four EAE studies and one cuprizone model). Nimodipine was administered using heterogeneous regimens (oral, intravenous, intraperitoneal, subcutaneous, or osmotic pump delivery; 1-30 mg/kg/day). The included studies reported the variable effects of nimodipine on relapse-related outcomes, myelination, inflammatory processes, and neuroprotection in the EAE model of MS. Across EAE studies, nimodipine generally reduced clinical disease severity or cumulative burden, although relapse-related outcomes were inconsistent. CONCLUSIONS: Preclinical evidence suggests that nimodipine may attenuate disease severity and demyelination and may promote repair-related processes in rodent models relevant to MS. However, to evaluate the clinical applicability of nimodipine in MS patients, well-powered, transparently reported preclinical replication and early-phase clinical studies are required before clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NimodipineMultiple SclerosisDemyelinating DiseasesAnimalsEncephalomyelitis, Autoimmune, ExperimentalDisease Models, AnimalCuprizoneNeuroprotective Agents

Stichwörter der Autor:innen

DemyelinationExperimental autoimmune encephalomyelitisMultiple SclerosisNeuroinflammationNeuroprotectionNimodipine

Substanzen

NimodipineCuprizoneNeuroprotective Agents

Autor:innen und Institutionen

  • Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Vakilipourp@tbzmed.ac.ir.
  • Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran.
  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Förderung

  • Tabriz University of Medical Sciences Student Research Committee

Zitieren

APA

Vakilipour, P., Sadigh-Eteghad, S., Naseri, A., & Bonabi, M. A. (2026). Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic review. Brain Research. https://doi.org/10.1016/j.brainres.2026.150479

Vancouver

Vakilipour P, Sadigh-Eteghad S, Naseri A, Bonabi MA. Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic review. Brain Research. 2026. doi:10.1016/j.brainres.2026.150479

BibTeX
@article{Vakilipour2026,
  author = {Vakilipour, Pouya and Sadigh-Eteghad, Saeed and Naseri, Amirreza and Bonabi, Melika Ahmadi},
  title = {Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic review},
  journal = {Brain Research},
  year = {2026},
  doi = {10.1016/j.brainres.2026.150479}
}
Kostenlos starten →